Versor Investments LP Purchases Shares of 19,100 Global Medical REIT Inc. (NYSE:GMRE)

Versor Investments LP bought a new stake in shares of Global Medical REIT Inc. (NYSE:GMREFree Report) during the 3rd quarter, according to its most recent filing with the SEC. The fund bought 19,100 shares of the company’s stock, valued at approximately $189,000.

A number of other institutional investors also recently added to or reduced their stakes in GMRE. Gordian Capital Singapore Pte Ltd acquired a new position in Global Medical REIT during the second quarter valued at approximately $100,000. M&G Plc acquired a new stake in Global Medical REIT during the first quarter worth about $141,000. M&G PLC bought a new position in shares of Global Medical REIT in the 3rd quarter valued at $193,000. First Trust Direct Indexing L.P. lifted its stake in Global Medical REIT by 25.6% in the 3rd quarter. First Trust Direct Indexing L.P. now owns 20,432 shares of the company’s stock valued at $202,000 after purchasing an additional 4,164 shares during the last quarter. Finally, SG Americas Securities LLC raised its position in Global Medical REIT by 90.1% in the third quarter. SG Americas Securities LLC now owns 22,700 shares of the company’s stock valued at $225,000 after purchasing an additional 10,759 shares during the last quarter. 57.52% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several research analysts have commented on the company. Berenberg Bank assumed coverage on Global Medical REIT in a report on Friday, October 18th. They set a “buy” rating and a $11.75 target price on the stock. Alliance Global Partners assumed coverage on shares of Global Medical REIT in a research note on Thursday, September 19th. They set a “buy” rating and a $12.00 target price on the stock.

Check Out Our Latest Stock Analysis on GMRE

Global Medical REIT Price Performance

Shares of NYSE GMRE opened at $8.63 on Friday. Global Medical REIT Inc. has a fifty-two week low of $7.98 and a fifty-two week high of $11.59. The stock has a market cap of $576.48 million, a PE ratio of -431.53, a price-to-earnings-growth ratio of 1.50 and a beta of 1.25. The company has a debt-to-equity ratio of 1.26, a quick ratio of 0.29 and a current ratio of 0.28. The stock has a fifty day moving average of $9.42 and a 200-day moving average of $9.22.

Global Medical REIT (NYSE:GMREGet Free Report) last posted its quarterly earnings data on Wednesday, November 6th. The company reported $0.03 earnings per share for the quarter, missing the consensus estimate of $0.21 by ($0.18). The company had revenue of $34.26 million for the quarter, compared to analysts’ expectations of $34.88 million. Global Medical REIT had a net margin of 3.23% and a return on equity of 0.86%. During the same quarter last year, the business posted $0.23 EPS. Equities research analysts anticipate that Global Medical REIT Inc. will post 0.85 earnings per share for the current year.

Global Medical REIT Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, October 8th. Shareholders of record on Friday, September 20th were issued a $0.21 dividend. The ex-dividend date was Friday, September 20th. This represents a $0.84 annualized dividend and a yield of 9.73%. Global Medical REIT’s dividend payout ratio (DPR) is presently -4,197.90%.

Global Medical REIT Profile

(Free Report)

Global Medical REIT Inc (GMRE) is a net-lease medical office real estate investment trust (REIT) that owns and acquires healthcare facilities and leases those facilities to physician groups and regional and national healthcare systems.

Read More

Want to see what other hedge funds are holding GMRE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Global Medical REIT Inc. (NYSE:GMREFree Report).

Institutional Ownership by Quarter for Global Medical REIT (NYSE:GMRE)

Receive News & Ratings for Global Medical REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Global Medical REIT and related companies with MarketBeat.com's FREE daily email newsletter.